Ernesto Oviedo-Orta

Ernesto Oviedo-Orta, MD, is a clinical sciences expert and senior principal scientist specializing in immunology and infectious diseases, currently affiliated with Merck KGaA and previously with Regeneron Pharmaceuticals.[1][3] He earned his medical degree from Havana Medical School in Cuba, where he specialized in clinical immunology, and has conducted research at institutions like the University of Surrey.[2][4] Oviedo-Orta has contributed to publications on topics such as COVID-19 treatments and immune cell communication, and serves on editorial boards in immunology.[3][5][6]